feed,title,long_url,short_url
Benzinga,"Galecto's GB0139 Shows Favorable Safety In COVID-19 Patients, But Plans To Focus On Fibrosis, Cancer Programs",https://benzinga.com/general/biotech/21/06/21669205/galectos-gb0139-shows-favorable-safety-in-covid-19-patients-but-plans-to-focus-on-fibrosis-cancer,https://j.mp/2Unc305
Benzinga,Biofrontera Stock Moves Higher On Outlining Clinical Update,https://benzinga.com/news/21/06/21668685/biofrontera-stock-moves-higher-on-outlining-clinical-update,https://j.mp/2TVIKS2
